Suppr超能文献

硝羟喹啉对从中国分离出的尿路病原体的抗菌活性。

antimicrobial activity of nitroxoline against uropathogens isolated from China.

作者信息

Yi Xiaofei, Chen Xin, Lu Yanyan, Zhang Jianfeng, Chen Jinhong, Wang Minggui, Xu Xiaogang

机构信息

Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 20040, China.

出版信息

JAC Antimicrob Resist. 2025 Feb 4;7(1):dlaf012. doi: 10.1093/jacamr/dlaf012. eCollection 2025 Feb.

Abstract

BACKGROUND AND OBJECTIVES

The antimicrobial nitroxoline is used in treating uncomplicated urinary tract infections (UTIs) in some European countries. antimicrobial data on uropathogens from China are lacking. To investigate the activity of nitroxoline against uropathogens isolated from Chinese patients.

METHODS

MICs of nitroxoline were determined using broth microdilution of 229 bacterial isolates of 10 species including derived from urinary sample. The EUCAST susceptibility breakpoint for (16 mg/L) was applied for all isolates. The MBC for ( = 34) was determined, with the MBC defined as the nitroxoline concentration at which a 99.9% reduction in the initial inoculum was observed. Time-kill curves of the two isolates of were tested over a 24 h period.

RESULTS

Except for , most isolates were susceptible to nitroxoline. The MIC50/90 values of nitroxoline for , and were 4/8, 8/32 and 8/16 mg/L, respectively. Among the Gram-negative isolates, nitroxoline demonstrated a better inhibitory effect against with an MIC50/90 value of 2/2 mg/L. The MBC of was equal to the MIC or one dilution higher. The time-kill curves of displayed concentration-dependent killing.

CONCLUSIONS

Nitroxoline showed excellent activity against uropathogens isolated from China and may be a good option for uncomplicated UTIs caused by , which are more challenging and have few clinical options. Further efficacy studies are needed.

摘要

背景与目的

在一些欧洲国家,抗菌药物硝咯喹啉用于治疗单纯性尿路感染(UTIs)。目前缺乏来自中国的尿路病原菌的抗菌数据。本研究旨在调查硝咯喹啉对从中国患者中分离出的尿路病原菌的活性。

方法

采用肉汤微量稀释法测定了从尿液样本中分离出的包括10个菌种的229株细菌对硝咯喹啉的最低抑菌浓度(MIC)。所有分离株均采用欧洲抗菌药物敏感性试验委员会(EUCAST)规定的硝咯喹啉敏感性折点(16mg/L)。测定了34株大肠埃希菌的最低杀菌浓度(MBC),MBC定义为观察到初始接种菌量减少99.9%时的硝咯喹啉浓度。对两株大肠埃希菌进行了24小时的时间杀菌曲线测试。

结果

除奇异变形杆菌外,大多数分离株对硝咯喹啉敏感。硝咯喹啉对大肠埃希菌、肺炎克雷伯菌和粪肠球菌的MIC50/90值分别为4/8、8/32和8/16mg/L。在革兰阴性菌分离株中,硝咯喹啉对奇异变形杆菌的抑制作用较好,MIC50/90值为2/2mg/L。大肠埃希菌的MBC等于MIC或高一个稀释度。大肠埃希菌的时间杀菌曲线显示出浓度依赖性杀菌作用。

结论

硝咯喹啉对从中国患者中分离出的尿路病原菌显示出优异的抗菌活性,对于由奇异变形杆菌引起的更具挑战性且临床治疗选择较少的单纯性UTIs可能是一个很好的选择。还需要进一步的疗效研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66e/11791683/118becc9a224/dlaf012f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验